KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Account Payables (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Account Payables for 16 consecutive years, with -$952000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 181.72% to -$952000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.1 million, a 8123.08% decrease, with the full-year FY2025 number at -$2.1 million, down 8123.08% from a year prior.
  • Change in Account Payables was -$952000.0 for Q4 2025 at Biolife Solutions, down from -$679000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.2 million in Q3 2021 to a low of -$5.0 million in Q4 2023.
  • A 5-year average of -$402650.0 and a median of -$192000.0 in 2022 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: soared 723.39% in 2021, then plummeted 2729.24% in 2023.
  • Biolife Solutions' Change in Account Payables stood at $650000.0 in 2021, then surged by 519.85% to $4.0 million in 2022, then crashed by 225.22% to -$5.0 million in 2023, then soared by 123.09% to $1.2 million in 2024, then plummeted by 181.72% to -$952000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Change in Account Payables are -$952000.0 (Q4 2025), -$679000.0 (Q3 2025), and $373000.0 (Q2 2025).